Anti-infective drug study in critically ill ECMO patients
Part of Infections clinical trials.
This study looks at how well antibiotics and other anti-infective drugs work in very sick patients who are on a heart-lung machine called ECMO. If you're in the ICU with a serious infection, this trial could help doctors figure out the best dose for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or a family member must agree to participate and sign a consent form.
- You are either currently on ECMO (a machine that helps your heart and lungs) or might need it.
- You have an infection that needs treatment with antibiotics or other anti-infective medications.
- You must be 18 years old or older and not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well certain strong antibiotics (Piperacillin-Tazobactam, Cefepime, or Meropenem) work in the body when a person is on a heart-lung machine called VA-ECMO. It aims to find the best dose for these antibiotics in this situation.
This trial looks at whether and when a heart-lung machine called ECMO should be used in children whose septic shock is not responding to standard treatment. It may help doctors choose the best timing to improve survival and recovery in the PICU.
This trial looks at using a specific heart-lung support machine (the EUROSETS ECMOLIFE system) for adults who need urgent “extra” circulation support. It may help clinicians understand how well the device works in serious situations like shock, cardiac arrest, or after heart surgery.
This trial is for people with severe lung failure (ARDS) who are already on a life-support machine called VV-ECMO. It tests whether adding a special breathing tube (CPAP) can help their lungs heal better.
This study examines how blood clotting cells (platelets) behave when patients are on a heart-lung support machine called ECMO. Researchers will take small blood samples to understand if the machine affects platelet function and how to manage blood thinning medication safely.
This trial studies how well certain new antibiotics work in patients with gram-negative bacterial infections who are receiving extracorporeal life support (like ECMO or dialysis) in the intensive care unit. It uses drug monitoring to make sure the right dose is given.
Hear when a new Critical Illness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.